Travel Restrictions, Guidelines, and Precautions
26 Feb
This report provides an update to the international situation as of February 20, 2010. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
26 Feb
During week 7 (February 14-20, 2010), influenza activity remained at approximately the same levels as last week in the U.S. 185 (4.4%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division were positive for influenza.
26 Feb
FluView reports that for the week of February 14 – February 20, 2010, flu activity in the United States was relatively low, with most flu continuing to be caused by 2009 H1N1. Flu activity, caused by either 2009 H1N1 or seasonal flu viruses, may rise and fall, but is expected to continue for weeks. It’s possible that the United States could experience another wave of flu activity caused by either 2009 H1N1 or seasonal influenza.
26 Feb
As of 21 February 2010, worldwide more than 213 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including at least 16226 deaths.
24 Feb
Questions and answers related to underlying health conditions among adults and children hospitalized with 2009 H1N1 in the United States from April 2009 through February 16, 2010.
24 Feb
This page provides a summary of the Behavioral Risk Factor Surveillance System (BRFSS) and how it helps track influenza activity.
24 Feb
This page provides summary information about the impact of 2009 H1N1 across racial and ethnic groups in the United States.
24 Feb
The Emergency Committee held its seventh meeting by teleconference on 23 February 2010. The Director-General sought the Committee’s views on the determination of the pandemic status.
22 Feb
Target audience: State health planners
This document is intended to provide PHER funded grantees with information regarding the reduction of vaccine inventory and allocation at the McKesson 2009 H1N1 vaccine/ancillary supply distribution depots.
22 Feb
Target audience: State health planners.
This document is intended to provide PHER funded grantees with information regarding the reduction of vaccine inventory and allocation at the McKesson 2009 H1N1 vaccine/ancillary supply distribution depots.
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ||||||||